Asiri Surgical Hospital Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Karunamuni Manjula Karunaratne

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	18.8yrs
CEO sahipliği	0.00003%
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	18.3yrs

Son yönetim güncellemeleri

Recent updates

CEO

Karunamuni Manjula Karunaratne

18.8yrs

Görev süresi

Dr. Karunamuni Manjula Prasanna Karunaratne, MBBS, M.Sc (Trinity, Dublin), Dip. MS Med (UK) MSOrth Med. (Eng), serves as the Group Chief Executive Officer at Asiri Hospital Holdings PLC and has been its Ex...

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
R. Ashok Pathirage	Chairman & MD	18.3yrs	Veri yok	Veri yok
Karunamuni Manjula Karunaratne	Group CEO & Director	18.8yrs	Veri yok	0.000030% LKR 1.8k
Haresh Kaimal	Non-Independent Non-Executive Director	less than a year	Veri yok	Veri yok

18.3yrs

Ortalama Görev Süresi

Deneyimli Yönetim Kurulu: AMSL.N0000 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 18.3 yıldır).

Asiri Surgical Hospital Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

Less than half of directors are independent

Asiri Surgical Hospital plc Announces Retirement of Mr. Gardiya Lokuge Harris Premaratne as Director

Asiri Surgical Hospital PLC, Annual General Meeting, Sep 30, 2024

Asiri Surgical Hospital plc Appoints Dr. Sivakumar Selliah as Senior Independent Director

Asiri Surgical Hospital plc Appoints Dr. Sivakumar Selliah as Senior Independent Director

Asiri Surgical Hospital PLC, Annual General Meeting, Sep 25, 2023

Recent updates

Less than half of directors are independent

Asiri Surgical Hospital plc Announces Retirement of Mr. Gardiya Lokuge Harris Premaratne as Director

New minor risk - Dividend sustainability

Upcoming dividend of LK₨0.30 per share

Asiri Surgical Hospital PLC, Annual General Meeting, Sep 30, 2024

First quarter 2025 earnings released: EPS: LK₨0.29 (vs LK₨0.36 in 1Q 2024)

New minor risk - Share price stability

Full year 2024 earnings released: EPS: LK₨1.12 (vs LK₨1.05 in FY 2023)

Third quarter 2024 earnings released: EPS: LK₨0.22 (vs LK₨0.36 in 3Q 2023)

New minor risk - Share price stability

Asiri Surgical Hospital plc Appoints Dr. Sivakumar Selliah as Senior Independent Director

Asiri Surgical Hospital plc Appoints Dr. Sivakumar Selliah as Senior Independent Director

Second quarter 2024 earnings released: EPS: LK₨0.28 (vs LK₨0.33 in 2Q 2023)

Asiri Surgical Hospital PLC, Annual General Meeting, Sep 25, 2023

Insufficient new directors

First quarter 2024 earnings released: EPS: LK₨0.36 (vs LK₨0.27 in 1Q 2023)

New minor risk - Profit margin trend

Full year 2023 earnings released: EPS: LK₨1.04 (vs LK₨2.24 in FY 2022)

Third quarter 2023 earnings released: EPS: LK₨0.36 (vs LK₨0.78 in 3Q 2022)

Investor sentiment improved over the past week

Second quarter 2023 earnings released: EPS: LK₨0.33 (vs LK₨0.49 in 2Q 2022)

Now 21% undervalued after recent price drop

Asiri Surgical Hospital PLC, Annual General Meeting, Aug 19, 2022

Full year 2022 earnings released: EPS: LK₨2.25 (vs LK₨1.56 in FY 2021)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of LK₨0.90 per share

Investor sentiment improved over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Inaugural dividend of LK₨1.20 per share

Second quarter 2022 earnings released: EPS LK₨0.49 (vs LK₨0.29 in 2Q 2021)

First quarter 2022 earnings released: EPS LK₨0.38 (vs LK₨0.093 loss in 1Q 2021)

New 90-day low: LK₨13.20

Investor sentiment improved over the past week

Market bids up stock over the past week

New 90-day high: LK₨14.50

First half earnings released

New 90-day high: LK₨13.00

New 90-day high - LK₨10.60

First quarter earnings released

CEO

Görev süresi

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi